Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs
Open Access
- 22 August 2023
- journal article
- research article
- Published by Elsevier in Drug Resistance Updates
- Vol. 71, 101002
Abstract
No abstract availableKeywords
Funding Information
- Department of Education of Liaoning Province
- Scientific Research Fund of Liaoning Provincial Education Department (LJKZ0743)
- National Natural Science Foundation of China (82373074)
- Natural Science Foundation of Liaoning Province (2022-YGJC-52)
This publication has 135 references indexed in Scilit:
- Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited MetastasesJournal of Clinical Oncology, 2013
- Mechanisms of chemoresistance in cancer stem cellsClinical and Translational Medicine, 2013
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistanceDrug Resistance Updates, 2011
- Parameters for individualizing systemic therapy in non-small cell lung cancerDrug Resistance Updates, 2010
- Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73Breast Cancer Research and Treatment, 2010
- Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 StudyJournal of Clinical Oncology, 2009
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine KinaseCancer Research, 2009
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate CancerScience, 2009
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyJournal of Clinical Oncology, 2008